Valuation: MindMaze Therapeutics Holding SA

Market Cap 22.54M 26.73M 24.35M 20.39M 38.25M 2.5B 40.03M 272M 108M 1.35B 100M 98.17M 4.27B P/E 2026 *
-2.01x
P/E 2027 * 2.65x
Enterprise Value 17.37M 20.59M 18.76M 15.71M 29.47M 1.92B 30.84M 210M 83.26M 1.04B 77.25M 75.63M 3.29B EV / Sales 2026 *
5.63x
EV / Sales 2027 * 0.53x
Free-Float
34.81%
Yield 2026 *
-
Yield 2027 * -
1 day-4.07%
1 week-8.23%
Current month-14.40%
1 month-14.63%
3 months-32.98%
6 months-70.42%
Current year-93.31%
1 week 0.13
Extreme 0.126
0.14
1 month 0.13
Extreme 0.126
0.17
Current year 0.13
Extreme 0.126
1.87
1 year 0.13
Extreme 0.126
2.92
3 years 0.13
Extreme 0.126
2.92
5 years 0.13
Extreme 0.126
2.92
10 years 0.13
Extreme 0.126
2.92
Date Insider Type Main position Quantity % Market Cap. Importance
19/12/25 Sell 140,000 0.0908%
19/12/25 Sell 52,162 0.0338%
19/12/25 Sell 281,968 0.1830%
Change 5-day change 1-year change 3-year change Capi.($)
-4.98%-8.23% - - 26.73M
-2.49%-6.35%+51.07%+64.95% 65.42B
-0.51%-2.80%+6.33%+89.44% 58.91B
-2.05%-2.16%+22.94%+82.42% 55.24B
-0.73%-4.95%+13.35%+110.73% 45.66B
-0.55%-6.58%+14.08%+20.65% 41.29B
-0.93%+1.67%+20.83%+45.03% 36.82B
+2.83%-4.34%+135.86%+658.49% 34.48B
-0.80%+0.61%+77.26%+56.26% 32.5B
+1.10%+20.19%-27.06%+491.47% 31.69B
Average -0.80%-1.09%+34.96%+179.94% 40B
Weighted average by Cap. -0.70%-1.28%+33.03%+153.60%

Financials

2026 *2027 *
Net sales 3.09M 3.66M 3.33M 2.79M 5.24M 342M 5.48M 37.3M 14.8M 185M 13.73M 13.44M 585M 28.23M 33.47M 30.5M 25.54M 47.91M 3.13B 50.14M 341M 135M 1.69B 126M 123M 5.35B
Net income -8.29M -9.83M -8.96M -7.5M -14.07M -918M -14.72M -100M -39.75M -496M -36.88M -36.1M -1.57B 10.38M 12.3M 11.21M 9.38M 17.61M 1.15B 18.43M 125M 49.75M 621M 46.15M 45.18M 1.97B
Net Debt -5.18M -6.14M -5.59M -4.68M -8.78M -573M -9.19M -62.57M -24.82M -310M -23.02M -22.54M -981M -7.65M -9.07M -8.26M -6.92M -12.98M -847M -13.58M -92.46M -36.68M -458M -34.03M -33.31M -1.45B
Projected Income Statement - Annual - MindMaze Therapeutics Holding SA
Logo MindMaze Therapeutics Holding SA
MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.
Employees
-
Date Price Change Volume
20/11/26 CHF 0.1264 -4.68% 875,410
19/11/26 CHF 0.1326 -1.49% 404,255
18/11/26 CHF 0.1346 -2.32% 739,251
17/11/26 CHF 0.1378 -1.43% 398,461
16/11/26 CHF 0.1398 +0.87% 400,478
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
MarketScreener Ratings - MindMaze Therapeutics Holding SA

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - MindMaze Therapeutics Holding SA